Review



pfizer-biontech covid-19 vaccine (2-doses, im  (BioNTech)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    BioNTech pfizer-biontech covid-19 vaccine (2-doses, im
    Pfizer Biontech Covid 19 Vaccine (2 Doses, Im, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pfizer-biontech+covid-19+vaccine+(2-doses%2C+im/bnt162b2/pm39858903-217-3-3
    Average 90 stars, based on 1 article reviews
    pfizer-biontech covid-19 vaccine (2-doses, im - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Vaccines:

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.
    Article Snippet: Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older?

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
    Article Snippet: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine.html , 2021 [ ] Accessed on 5 November 2024. , Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older? , Report , The pooled VE estimates from the observational studies (OS) demonstrate that the Pfizer-BioNTech vaccine reduced symptomatic COVID-19 when it was compared to no vaccination..

    Article Title: Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
    Article Snippet: The policy question under consideration was, “Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, intramuscularly, IM) be recommended for persons 16 years of age and older?”.

    Activity Assay:

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.
    Article Snippet: Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older?

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
    Article Snippet: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine.html , 2021 [ ] Accessed on 5 November 2024. , Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older? , Report , The pooled VE estimates from the observational studies (OS) demonstrate that the Pfizer-BioNTech vaccine reduced symptomatic COVID-19 when it was compared to no vaccination..

    Article Title: Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
    Article Snippet: The policy question under consideration was, “Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, intramuscularly, IM) be recommended for persons 16 years of age and older?”.

    Infection:

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.
    Article Snippet: Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older?

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
    Article Snippet: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine.html , 2021 [ ] Accessed on 5 November 2024. , Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older? , Report , The pooled VE estimates from the observational studies (OS) demonstrate that the Pfizer-BioNTech vaccine reduced symptomatic COVID-19 when it was compared to no vaccination..

    Article Title: Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
    Article Snippet: The policy question under consideration was, “Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, intramuscularly, IM) be recommended for persons 16 years of age and older?”.

    Virus:

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.
    Article Snippet: Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older?

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
    Article Snippet: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine.html , 2021 [ ] Accessed on 5 November 2024. , Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older? , Report , The pooled VE estimates from the observational studies (OS) demonstrate that the Pfizer-BioNTech vaccine reduced symptomatic COVID-19 when it was compared to no vaccination..

    Article Title: Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
    Article Snippet: The policy question under consideration was, “Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, intramuscularly, IM) be recommended for persons 16 years of age and older?”.

    Variant Assay:

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.
    Article Snippet: Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older?

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
    Article Snippet: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine.html , 2021 [ ] Accessed on 5 November 2024. , Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older? , Report , The pooled VE estimates from the observational studies (OS) demonstrate that the Pfizer-BioNTech vaccine reduced symptomatic COVID-19 when it was compared to no vaccination..

    Article Title: Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
    Article Snippet: The policy question under consideration was, “Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, intramuscularly, IM) be recommended for persons 16 years of age and older?”.

    Neutralization:

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.
    Article Snippet: Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older?

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
    Article Snippet: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine.html , 2021 [ ] Accessed on 5 November 2024. , Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older? , Report , The pooled VE estimates from the observational studies (OS) demonstrate that the Pfizer-BioNTech vaccine reduced symptomatic COVID-19 when it was compared to no vaccination..

    Article Title: Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
    Article Snippet: The policy question under consideration was, “Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, intramuscularly, IM) be recommended for persons 16 years of age and older?”.

    Plasmid Preparation:

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.
    Article Snippet: Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older?

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
    Article Snippet: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine.html , 2021 [ ] Accessed on 5 November 2024. , Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older? , Report , The pooled VE estimates from the observational studies (OS) demonstrate that the Pfizer-BioNTech vaccine reduced symptomatic COVID-19 when it was compared to no vaccination..

    Article Title: Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
    Article Snippet: The policy question under consideration was, “Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, intramuscularly, IM) be recommended for persons 16 years of age and older?”.

    Binding Assay:

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.
    Article Snippet: Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older?

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
    Article Snippet: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine.html , 2021 [ ] Accessed on 5 November 2024. , Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older? , Report , The pooled VE estimates from the observational studies (OS) demonstrate that the Pfizer-BioNTech vaccine reduced symptomatic COVID-19 when it was compared to no vaccination..

    Article Title: Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
    Article Snippet: The policy question under consideration was, “Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, intramuscularly, IM) be recommended for persons 16 years of age and older?”.

    Recombinant:

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.
    Article Snippet: Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older?

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
    Article Snippet: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine.html , 2021 [ ] Accessed on 5 November 2024. , Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older? , Report , The pooled VE estimates from the observational studies (OS) demonstrate that the Pfizer-BioNTech vaccine reduced symptomatic COVID-19 when it was compared to no vaccination..

    Article Title: Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
    Article Snippet: The policy question under consideration was, “Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, intramuscularly, IM) be recommended for persons 16 years of age and older?”.

    Injection:

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.
    Article Snippet: Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older?

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
    Article Snippet: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine.html , 2021 [ ] Accessed on 5 November 2024. , Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older? , Report , The pooled VE estimates from the observational studies (OS) demonstrate that the Pfizer-BioNTech vaccine reduced symptomatic COVID-19 when it was compared to no vaccination..

    Article Title: Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
    Article Snippet: The policy question under consideration was, “Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, intramuscularly, IM) be recommended for persons 16 years of age and older?”.

    Functional Assay:

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.
    Article Snippet: Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older?

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
    Article Snippet: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine.html , 2021 [ ] Accessed on 5 November 2024. , Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older? , Report , The pooled VE estimates from the observational studies (OS) demonstrate that the Pfizer-BioNTech vaccine reduced symptomatic COVID-19 when it was compared to no vaccination..

    Article Title: Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
    Article Snippet: The policy question under consideration was, “Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, intramuscularly, IM) be recommended for persons 16 years of age and older?”.

    Derivative Assay:

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.
    Article Snippet: Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older?

    Article Title: COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
    Article Snippet: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech-vaccine.html , 2021 [ ] Accessed on 5 November 2024. , Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older? , Report , The pooled VE estimates from the observational studies (OS) demonstrate that the Pfizer-BioNTech vaccine reduced symptomatic COVID-19 when it was compared to no vaccination..

    Article Title: Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
    Article Snippet: The policy question under consideration was, “Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, intramuscularly, IM) be recommended for persons 16 years of age and older?”.



    Similar Products

    90
    BioNTech pfizer-biontech covid-19 vaccine (2-doses, im
    Pfizer Biontech Covid 19 Vaccine (2 Doses, Im, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pfizer-biontech+covid-19+vaccine+(2-doses%2C+im/bnt162b2/pm39858903-217-3-3
    Average 90 stars, based on 1 article reviews
    pfizer-biontech covid-19 vaccine (2-doses, im - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results